Detalhe da pesquisa
1.
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
J Neurol Neurosurg Psychiatry
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569872
2.
Risk of secondary progressive multiple sclerosis after early worsening of disability.
J Neurol Neurosurg Psychiatry
; 94(12): 984-991, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414538
3.
Disability accrual in primary and secondary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(9): 707-717, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068931
4.
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.
J Neurol Neurosurg Psychiatry
; 94(12): 1004-1011, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414534
5.
Comparative effectiveness in multiple sclerosis: A methodological comparison.
Mult Scler
; 29(3): 326-332, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36800908
6.
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Eur J Neurol
; 30(4): 1014-1024, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692895
7.
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS.
Mult Scler
; 28(11): 1752-1761, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35373638
8.
Confirmed disability progression as a marker of permanent disability in multiple sclerosis.
Eur J Neurol
; 29(8): 2321-2334, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582938
9.
Determinants of therapeutic lag in multiple sclerosis.
Mult Scler
; 27(12): 1838-1851, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423618
10.
Delay from treatment start to full effect of immunotherapies for multiple sclerosis.
Brain
; 143(9): 2742-2756, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32947619
11.
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
JAMA Neurol
; 80(7): 702-713, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37437240
12.
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.
Neurology
; 99(17): e1926-e1944, 2022 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977837
13.
Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study.
Neurology
; 98(24): e2401-e2412, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35410900
14.
Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry.
J Neurol Sci
; 430: 118067, 2021 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34537678
15.
Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a.
Neurology
; 96(2): e214-e227, 2021 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33024022
16.
Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis.
Neurology
; 2021 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33879599
17.
Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression.
Comput Methods Programs Biomed
; 208: 106180, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34146771
18.
Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180].
Comput Methods Programs Biomed
; 213: 106479, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34749246
19.
Role of electron microscopy in the diagnosis of cadasil syndrome: a study of 32 patients.
PLoS One
; 8(6): e65482, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23799017